Developing new treatments for childhood leukemia
Clinical Trials Specialist in Developmental Therapeutics
This study is all about finding better treatments for kids with leukemia by trying new ways to give medicine and making sure more children, especially from different backgrounds, can join in on these important trials, while also helping train future doctors in this field.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10920409 on NIH RePORTER |
What this research studies
This research focuses on enhancing treatment options for childhood leukemia by leading a team dedicated to developing and expanding clinical trials. The team will work on innovative methods, such as dose de-escalation of specific medications, to improve outcomes for young patients. Additionally, efforts will be made to increase participation in these trials, particularly among minority populations, ensuring that more children have access to potentially life-saving therapies. The project also emphasizes mentoring the next generation of researchers in pediatric oncology.
Who could benefit from this research
Good fit: Ideal candidates for participation are children aged 0-11 years diagnosed with leukemia or related myeloid diseases.
Not a fit: Patients with leukemia who are older than 21 years or those with conditions not related to myeloid diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and tailored treatments for children with leukemia, improving their chances of remission and overall survival.
How similar studies have performed: Previous research in pediatric oncology has shown success in developing innovative treatment approaches, indicating a promising potential for this project.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Hijiya, Nobuko — Columbia University Health Sciences
- Study coordinator: Hijiya, Nobuko
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.